SCHEMBL6604425

SCHEMBL6604425

CCN1CC=C(c2cccc(OC(C)C)c2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 5/20 0.46
DRD2 P14416 4/20 0.46
PPARG P37231 4/20 0.46
PPARA Q07869 4/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.44
ALOX15 P16050 2/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
CCNT1 O60563 1/20 0.44
CDK9 P50750 1/20 0.44
WDR5 P61964 1/20 0.44
PARP1 P09874 1/20 0.41
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
SIGMAR1 Q99720 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8352095 0.85 MEN1 (0.59) HTR1ADRD2PPARGPPARAMEN1
SCHEMBL16915272 0.83 QDPR (0.50) PPARGPPARAMEN1KMT2AGAA
SCHEMBL10241131 0.77 KDM4E (0.56) HTR1ADRD2KDM4ELMNAALOX15
SCHEMBL7369144 0.77 KDM4E (0.45) HTR1ADRD2MEN1KMT2AKDM4E
SCHEMBL11956942 0.76 GPR119 (0.47) PPARGPPARAKDM4ELMNAALOX15
SCHEMBL30689996 0.75 PPARG (0.49) HTR1APPARGPPARAMEN1KMT2A
SCHEMBL9020738 0.74 HTR7 (0.52) DRD2PPARGPPARAMEN1KMT2A
SCHEMBL2660796 0.72 MAPT (0.48) MEN1KMT2AKDM4ELMNAALOX15
SCHEMBL28017545 0.72 MEN1 (0.56) HTR1ADRD2PPARGPPARAMEN1
SCHEMBL4827185 0.71 MEN1 (0.71) HTR1ADRD2PPARGPPARAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1072601-B1 4-arylpiperidine derivatives for the treatment of pruritus PFIZER (US) 2004-09-08 EP disclosed
EP-1077940-B1 4-PHENYLPIPERIDINES FOR THE TREATMENT OF PRURITIC DERMATOSES PFIZER (US) 2004-07-14 EP disclosed
US-6750231-B2 SKIN DISORDERS; GASTROINTESTINAL DISORDERS PFIZER INC 2004-06-15 US disclosed
US-6610711-B2 4-phenylpiperidines for the treatment of pruritic dermatoses PFIZER INC. 2003-08-26 US disclosed
US-20030078282-A1 Novel 4-phenylpiperidines for the treatment of pruritic dermatoses PFIZER INC. 2003-04-24 US disclosed
US-20030004340-A1 New 4-arylpiperidine derivatives for the treatment of pruritus GIBSON STEPHEN PAUL (GB) 2003-01-02 US disclosed
EP-1077940-A1 4-PHENYLPIPERIDINES FOR THE TREATMENT OF PRURITIC DERMATOSES PFIZER INC. (US) 2001-02-28 EP disclosed
EP-1072601-A2 4-arylpiperidine derivatives for the treatment of pruritus PFIZER INC. (US) 2001-01-31 EP disclosed
WO-1999059971-A1 NOVEL 4-PHENYLPIPERIDINES FOR THE TREATMENT OF PRURITIC DERMATOSES PFIZER INC. (US) 1999-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030004340-A1 New 4-arylpiperidine derivatives for the treatment of pruritus HRH2, HRH4, HRH1 HTR1A 33/4885DRD2 148/4885PPARG 885/4885
US-20030078282-A1 Novel 4-phenylpiperidines for the treatment of pruritic dermatoses HRH2, HRH4, HRH1 HTR1A 51/4885DRD2 134/4885PPARG 1213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.